9 results
COVID-19 Diagnosis and Management Summary
Clinical and laboratory testing
Lung Ultrasound
HRCT scan
In-hospital treatment
Severity assessment and respiratory support 
Post-mortem
COVID-19 Diagnosis ... and Management ... Summary Clinical ... laboratory testing Lung ... #Diagnosis #Management
COVID-19 on Lung POCUS - Day 2

Day 2 after COVID diagnosis. Less sore throat, cough &
COVID-19 on Lung ... POCUS - Day 2 ... Day 2 after COVID ... diagnosis. ... #clinical #lung
COVID-19 on Lung POCUS

Day 4 after COVID diagnosis. More cough & tiredness (very badly), still no
COVID-19 on Lung ... POCUS Day 4 ... after COVID diagnosis ... more thickened pleural ... #clinical #lung
Day 10 after COVID diagnosis. Less tired, but more cough, ageusia & anosmia. No dyspnea or
Day 10 after COVID ... diagnosis. ... POCUS update: Right ... lateral with thick pleural ... #clinical #lung
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
emergency 2020-3-12 Diagnosis ... unilateral* • POCUS ... numerous B-lines, pleural ... #Cheatsheet #Diagnosis ... #Management #Summary
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... Rare: pleural effusions ... , pleural thickening ... Organizing Pneumonia Treatment ... #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... organ system: • Pleura ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... organ system: • Pleura ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... Xerotrachea • NSIP: Pleural ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... #Management